Boston Current Deferred Revenue from 2010 to 2024
| 0HOY Stock | 89.66 0.22 0.25% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 266 M | Current Value 214.7 M | Quarterly Volatility 40.2 M |
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 B, Total Revenue of 10.6 B or Gross Profit of 6.9 B, as well as many indicators such as . Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
Boston | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.